Precision medicine and personalized breast cancer: combination pertuzumab therapy

Trastuzumab (Herceptin), a monoclonal antibody directed against the human epidermal growth-factor receptor 2 (HER2), is the poster child for antibody-based targeted therapy in breast cancer. Pertuzumab, another humanized monoclonal antibody, binds to a different domain of HER2 and prevents the forma...

Descripción completa

Detalles Bibliográficos
Autores principales: Reynolds, Kerry, Sarangi, Sasmit, Bardia, Aditya, Dizon, Don S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977457/
https://www.ncbi.nlm.nih.gov/pubmed/24715764
http://dx.doi.org/10.2147/PGPM.S37100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977457/
https://www.ncbi.nlm.nih.gov/pubmed/24715764
http://dx.doi.org/10.2147/PGPM.S37100

Ejemplares similares